Novavax NVAX Milestones amortization — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's milestones amortization — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's milestones amortization — total revenue?
- Novavax (NVAX) reported milestones amortization — total revenue of $5.55M in Q1 2026.
- How has Novavax's milestones amortization — total revenue changed year-over-year?
- Novavax's milestones amortization — total revenue decreased by 39.3% year-over-year, from $9.14M to $5.55M.
- What does milestones amortization — total revenue mean?
- This metric represents the revenue recognized from the systematic amortization of upfront milestone payments received from licensing or collaboration agreements. It reflects the portion of deferred revenue allocated to the current period as the company fulfills its long-term performance obligations under these partnerships. This figure provides insight into the recurring financial benefit derived from historical research and development achievements and strategic commercial alliances.